nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxtriphylline—HDAC2—telencephalic ventricle—Alzheimer's disease	0.0334	0.1	CbGeAlD
Oxtriphylline—PDE3B—forebrain—Alzheimer's disease	0.0148	0.0444	CbGeAlD
Oxtriphylline—PDE4C—forebrain—Alzheimer's disease	0.0141	0.0421	CbGeAlD
Oxtriphylline—PDE4C—telencephalon—Alzheimer's disease	0.0129	0.0387	CbGeAlD
Oxtriphylline—PDE4D—telencephalon—Alzheimer's disease	0.0114	0.0341	CbGeAlD
Oxtriphylline—ADORA2A—forebrain—Alzheimer's disease	0.0102	0.0306	CbGeAlD
Oxtriphylline—PDE4A—telencephalon—Alzheimer's disease	0.0101	0.0302	CbGeAlD
Oxtriphylline—HDAC2—embryo—Alzheimer's disease	0.00987	0.0295	CbGeAlD
Oxtriphylline—ADORA2A—telencephalon—Alzheimer's disease	0.00941	0.0282	CbGeAlD
Oxtriphylline—ADORA1—forebrain—Alzheimer's disease	0.00884	0.0264	CbGeAlD
Oxtriphylline—HDAC2—forebrain—Alzheimer's disease	0.00873	0.0261	CbGeAlD
Oxtriphylline—ADORA1—telencephalon—Alzheimer's disease	0.00813	0.0243	CbGeAlD
Oxtriphylline—HDAC2—telencephalon—Alzheimer's disease	0.00803	0.024	CbGeAlD
Oxtriphylline—PDE4C—nervous system—Alzheimer's disease	0.00764	0.0229	CbGeAlD
Oxtriphylline—PDE3B—cerebellum—Alzheimer's disease	0.00759	0.0227	CbGeAlD
Oxtriphylline—PDE4C—central nervous system—Alzheimer's disease	0.00736	0.022	CbGeAlD
Oxtriphylline—ADORA2B—nervous system—Alzheimer's disease	0.00668	0.02	CbGeAlD
Oxtriphylline—PDE4B—forebrain—Alzheimer's disease	0.00654	0.0196	CbGeAlD
Oxtriphylline—ADORA2B—central nervous system—Alzheimer's disease	0.00643	0.0192	CbGeAlD
Oxtriphylline—PDE4D—cerebellum—Alzheimer's disease	0.00633	0.0189	CbGeAlD
Oxtriphylline—ADORA2B—cerebellum—Alzheimer's disease	0.00629	0.0188	CbGeAlD
Oxtriphylline—PDE3B—brain—Alzheimer's disease	0.00616	0.0184	CbGeAlD
Oxtriphylline—PDE4B—telencephalon—Alzheimer's disease	0.00601	0.018	CbGeAlD
Oxtriphylline—PDE4C—brain—Alzheimer's disease	0.00584	0.0175	CbGeAlD
Oxtriphylline—PDE4A—cerebellum—Alzheimer's disease	0.0056	0.0168	CbGeAlD
Oxtriphylline—ADORA2A—nervous system—Alzheimer's disease	0.00556	0.0166	CbGeAlD
Oxtriphylline—ADORA2A—central nervous system—Alzheimer's disease	0.00535	0.016	CbGeAlD
Oxtriphylline—ADORA2A—cerebellum—Alzheimer's disease	0.00523	0.0156	CbGeAlD
Oxtriphylline—PDE4D—brain—Alzheimer's disease	0.00514	0.0154	CbGeAlD
Oxtriphylline—ADORA2B—brain—Alzheimer's disease	0.00511	0.0153	CbGeAlD
Oxtriphylline—ADORA1—nervous system—Alzheimer's disease	0.0048	0.0144	CbGeAlD
Oxtriphylline—HDAC2—nervous system—Alzheimer's disease	0.00474	0.0142	CbGeAlD
Oxtriphylline—PDE3A—cerebellum—Alzheimer's disease	0.00463	0.0139	CbGeAlD
Oxtriphylline—ADORA1—central nervous system—Alzheimer's disease	0.00462	0.0138	CbGeAlD
Oxtriphylline—HDAC2—central nervous system—Alzheimer's disease	0.00456	0.0137	CbGeAlD
Oxtriphylline—PDE4A—brain—Alzheimer's disease	0.00455	0.0136	CbGeAlD
Oxtriphylline—ADORA1—cerebellum—Alzheimer's disease	0.00452	0.0135	CbGeAlD
Oxtriphylline—HDAC2—cerebellum—Alzheimer's disease	0.00446	0.0133	CbGeAlD
Oxtriphylline—ADORA2A—brain—Alzheimer's disease	0.00425	0.0127	CbGeAlD
Oxtriphylline—SLC22A7—brain—Alzheimer's disease	0.00421	0.0126	CbGeAlD
Oxtriphylline—PDE3A—brain—Alzheimer's disease	0.00376	0.0113	CbGeAlD
Oxtriphylline—ADORA1—brain—Alzheimer's disease	0.00367	0.011	CbGeAlD
Oxtriphylline—HDAC2—brain—Alzheimer's disease	0.00362	0.0108	CbGeAlD
Oxtriphylline—PDE4B—nervous system—Alzheimer's disease	0.00355	0.0106	CbGeAlD
Oxtriphylline—PDE4B—central nervous system—Alzheimer's disease	0.00342	0.0102	CbGeAlD
Oxtriphylline—PDE4B—cerebellum—Alzheimer's disease	0.00334	0.00999	CbGeAlD
Oxtriphylline—PDE4B—brain—Alzheimer's disease	0.00271	0.00812	CbGeAlD
Oxtriphylline—Theophylline—CYP2D6—Alzheimer's disease	0.00125	0.505	CrCbGaD
Oxtriphylline—Caffeine—CYP2D6—Alzheimer's disease	0.00123	0.495	CrCbGaD
Oxtriphylline—PDE4D—Signaling Pathways—NOTCH1—Alzheimer's disease	7.25e-05	0.000109	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—IGF1R—Alzheimer's disease	7.24e-05	0.000109	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CAV1—Alzheimer's disease	7.21e-05	0.000109	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	7.2e-05	0.000109	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—GSK3B—Alzheimer's disease	7.19e-05	0.000108	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—ESR1—Alzheimer's disease	7.14e-05	0.000108	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—CREB1—Alzheimer's disease	7.13e-05	0.000108	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—GSK3B—Alzheimer's disease	7.13e-05	0.000108	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	7.1e-05	0.000107	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—INS—Alzheimer's disease	7.09e-05	0.000107	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CREB1—Alzheimer's disease	7.07e-05	0.000107	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—F2—Alzheimer's disease	7.05e-05	0.000106	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—INS—Alzheimer's disease	7.04e-05	0.000106	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CALM1—Alzheimer's disease	7.03e-05	0.000106	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—LEP—Alzheimer's disease	7e-05	0.000106	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—APOE—Alzheimer's disease	7e-05	0.000106	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—TP53—Alzheimer's disease	7e-05	0.000105	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—IGF2—Alzheimer's disease	6.96e-05	0.000105	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—ESR1—Alzheimer's disease	6.94e-05	0.000105	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CALM1—Alzheimer's disease	6.94e-05	0.000105	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—LPL—Alzheimer's disease	6.94e-05	0.000105	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CAV1—Alzheimer's disease	6.94e-05	0.000105	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CCL2—Alzheimer's disease	6.92e-05	0.000104	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—LEP—Alzheimer's disease	6.92e-05	0.000104	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—APOE—Alzheimer's disease	6.92e-05	0.000104	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—GSK3B—Alzheimer's disease	6.92e-05	0.000104	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—NOTCH1—Alzheimer's disease	6.9e-05	0.000104	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—MEF2C—Alzheimer's disease	6.88e-05	0.000104	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CREB1—Alzheimer's disease	6.86e-05	0.000103	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—F2—Alzheimer's disease	6.86e-05	0.000103	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CAV1—Alzheimer's disease	6.86e-05	0.000103	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ND1—Alzheimer's disease	6.85e-05	0.000103	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—INS—Alzheimer's disease	6.82e-05	0.000103	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—IGF1—Alzheimer's disease	6.8e-05	0.000103	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—GSK3B—Alzheimer's disease	6.8e-05	0.000103	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—NOS3—Alzheimer's disease	6.76e-05	0.000102	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CREB1—Alzheimer's disease	6.75e-05	0.000102	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—PRKCG—Alzheimer's disease	6.75e-05	0.000102	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—IGF1R—Alzheimer's disease	6.73e-05	0.000101	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—NOTCH1—Alzheimer's disease	6.71e-05	0.000101	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CCL2—Alzheimer's disease	6.71e-05	0.000101	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—INS—Alzheimer's disease	6.71e-05	0.000101	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	6.7e-05	0.000101	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—ESR1—Alzheimer's disease	6.69e-05	0.000101	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—ESR1—Alzheimer's disease	6.61e-05	9.96e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CCL2—Alzheimer's disease	6.6e-05	9.96e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—F2—Alzheimer's disease	6.6e-05	9.96e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—IGF1—Alzheimer's disease	6.6e-05	9.95e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—NGF—Alzheimer's disease	6.57e-05	9.91e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—F2—Alzheimer's disease	6.53e-05	9.84e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—IGF1—Alzheimer's disease	6.49e-05	9.79e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—GSK3B—Alzheimer's disease	6.48e-05	9.76e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—NOTCH1—Alzheimer's disease	6.46e-05	9.74e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—LPL—Alzheimer's disease	6.45e-05	9.73e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CREB1—Alzheimer's disease	6.42e-05	9.69e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CCR5—Alzheimer's disease	6.39e-05	9.64e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—MEF2C—Alzheimer's disease	6.39e-05	9.64e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—INS—Alzheimer's disease	6.39e-05	9.63e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—NOTCH1—Alzheimer's disease	6.39e-05	9.63e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—GSK3B—Alzheimer's disease	6.3e-05	9.5e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CCL2—Alzheimer's disease	6.29e-05	9.48e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PRKCG—Alzheimer's disease	6.27e-05	9.46e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—HTR2A—Alzheimer's disease	6.26e-05	9.43e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CREB1—Alzheimer's disease	6.25e-05	9.42e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—NOS3—Alzheimer's disease	6.22e-05	9.38e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—INS—Alzheimer's disease	6.21e-05	9.37e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—IGF1—Alzheimer's disease	6.18e-05	9.32e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—NOS3—Alzheimer's disease	6.17e-05	9.3e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	6.13e-05	9.24e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CCL2—Alzheimer's disease	6.11e-05	9.22e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—NGF—Alzheimer's disease	6.11e-05	9.21e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—GSK3B—Alzheimer's disease	6.06e-05	9.14e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CREB1—Alzheimer's disease	6.02e-05	9.07e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—IGF1—Alzheimer's disease	6.01e-05	9.06e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—GSK3B—Alzheimer's disease	5.99e-05	9.04e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—NOS3—Alzheimer's disease	5.98e-05	9.02e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—INS—Alzheimer's disease	5.98e-05	9.02e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CREB1—Alzheimer's disease	5.94e-05	8.96e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CCR5—Alzheimer's disease	5.94e-05	8.96e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—INS—Alzheimer's disease	5.91e-05	8.91e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—AKT1—Alzheimer's disease	5.91e-05	8.91e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—NOS3—Alzheimer's disease	5.89e-05	8.87e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CCL2—Alzheimer's disease	5.89e-05	8.87e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CALM1—Alzheimer's disease	5.84e-05	8.8e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CCL2—Alzheimer's disease	5.82e-05	8.77e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—LEP—Alzheimer's disease	5.82e-05	8.77e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—APOE—Alzheimer's disease	5.82e-05	8.77e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—HTR2A—Alzheimer's disease	5.82e-05	8.77e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—GPCR downstream signaling—AKT1—Alzheimer's disease	5.79e-05	8.74e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—IGF1—Alzheimer's disease	5.79e-05	8.72e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CAV1—Alzheimer's disease	5.76e-05	8.69e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CASP3—Alzheimer's disease	5.74e-05	8.66e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—IGF1—Alzheimer's disease	5.72e-05	8.62e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—IL6—Alzheimer's disease	5.7e-05	8.6e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—PTGS2—Alzheimer's disease	5.69e-05	8.58e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—NOS3—Alzheimer's disease	5.6e-05	8.45e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—ESR1—Alzheimer's disease	5.55e-05	8.37e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—F2—Alzheimer's disease	5.48e-05	8.27e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—NOS3—Alzheimer's disease	5.45e-05	8.22e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CALM1—Alzheimer's disease	5.43e-05	8.18e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—LEP—Alzheimer's disease	5.41e-05	8.15e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—APOE—Alzheimer's disease	5.41e-05	8.15e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—NOTCH1—Alzheimer's disease	5.37e-05	8.09e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CAV1—Alzheimer's disease	5.36e-05	8.08e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	5.29e-05	7.97e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	5.28e-05	7.96e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—MAPK8—Alzheimer's disease	5.28e-05	7.95e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—AKT1—Alzheimer's disease	5.26e-05	7.93e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—NOS3—Alzheimer's disease	5.25e-05	7.91e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CASP3—Alzheimer's disease	5.24e-05	7.9e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—IL6—Alzheimer's disease	5.2e-05	7.85e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—NOS3—Alzheimer's disease	5.18e-05	7.82e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—ESR1—Alzheimer's disease	5.16e-05	7.78e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—AKT1—Alzheimer's disease	5.13e-05	7.73e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—F2—Alzheimer's disease	5.1e-05	7.69e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CASP3—Alzheimer's disease	5.08e-05	7.66e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—IL6—Alzheimer's disease	5.05e-05	7.61e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—AKT1—Alzheimer's disease	5.04e-05	7.6e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—GSK3B—Alzheimer's disease	5.04e-05	7.59e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CASP3—Alzheimer's disease	5e-05	7.53e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CREB1—Alzheimer's disease	5e-05	7.53e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	4.99e-05	7.52e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—INS—Alzheimer's disease	4.97e-05	7.49e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—IL6—Alzheimer's disease	4.96e-05	7.49e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CCL2—Alzheimer's disease	4.89e-05	7.37e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—VEGFA—Alzheimer's disease	4.87e-05	7.34e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—MAPK8—Alzheimer's disease	4.81e-05	7.26e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	4.81e-05	7.25e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—IGF1—Alzheimer's disease	4.81e-05	7.25e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—AKT1—Alzheimer's disease	4.8e-05	7.24e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—AKT1—Alzheimer's disease	4.8e-05	7.24e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CASP3—Alzheimer's disease	4.76e-05	7.17e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—IL6—Alzheimer's disease	4.73e-05	7.13e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—GSK3B—Alzheimer's disease	4.68e-05	7.06e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—AKT1—Alzheimer's disease	4.67e-05	7.04e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—MAPK8—Alzheimer's disease	4.67e-05	7.04e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—AKT1—Alzheimer's disease	4.66e-05	7.02e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CREB1—Alzheimer's disease	4.64e-05	7e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CASP3—Alzheimer's disease	4.63e-05	6.98e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—INS—Alzheimer's disease	4.62e-05	6.96e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—IL6—Alzheimer's disease	4.6e-05	6.93e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—MAPK8—Alzheimer's disease	4.59e-05	6.92e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—AKT1—Alzheimer's disease	4.58e-05	6.91e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CCL2—Alzheimer's disease	4.54e-05	6.85e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—AKT1—Alzheimer's disease	4.5e-05	6.78e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—TGFB1—Alzheimer's disease	4.47e-05	6.74e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—IGF1—Alzheimer's disease	4.47e-05	6.74e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CASP3—Alzheimer's disease	4.45e-05	6.72e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—VEGFA—Alzheimer's disease	4.44e-05	6.7e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—AKT1—Alzheimer's disease	4.44e-05	6.7e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—IL6—Alzheimer's disease	4.42e-05	6.67e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CHAT—Alzheimer's disease	4.42e-05	6.66e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—TPI1—Alzheimer's disease	4.42e-05	6.66e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CASP3—Alzheimer's disease	4.4e-05	6.64e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—IL6—Alzheimer's disease	4.37e-05	6.59e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—MAPK8—Alzheimer's disease	4.37e-05	6.59e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—AKT1—Alzheimer's disease	4.36e-05	6.57e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—NOS3—Alzheimer's disease	4.36e-05	6.57e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—VEGFA—Alzheimer's disease	4.31e-05	6.5e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—MAPK8—Alzheimer's disease	4.25e-05	6.41e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—AKT1—Alzheimer's disease	4.24e-05	6.39e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—VEGFA—Alzheimer's disease	4.24e-05	6.39e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—MAOB—Alzheimer's disease	4.23e-05	6.38e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—TGFB1—Alzheimer's disease	4.11e-05	6.2e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—MAPK8—Alzheimer's disease	4.09e-05	6.17e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—AKT1—Alzheimer's disease	4.08e-05	6.16e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—TGFB1—Alzheimer's disease	4.08e-05	6.15e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	4.08e-05	6.14e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—NOS3—Alzheimer's disease	4.05e-05	6.11e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—MAPK8—Alzheimer's disease	4.04e-05	6.1e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—VEGFA—Alzheimer's disease	4.04e-05	6.09e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—AKT1—Alzheimer's disease	4.03e-05	6.08e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	4.03e-05	6.08e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.99e-05	6.02e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—TGFB1—Alzheimer's disease	3.96e-05	5.97e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—A2M—Alzheimer's disease	3.94e-05	5.93e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—VEGFA—Alzheimer's disease	3.93e-05	5.92e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—TGFB1—Alzheimer's disease	3.89e-05	5.87e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—VEGFA—Alzheimer's disease	3.78e-05	5.7e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—VEGFA—Alzheimer's disease	3.73e-05	5.63e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—TGFB1—Alzheimer's disease	3.7e-05	5.59e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CASP3—Alzheimer's disease	3.7e-05	5.58e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—TP53—Alzheimer's disease	3.68e-05	5.55e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—TGFB1—Alzheimer's disease	3.6e-05	5.43e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.51e-05	5.29e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	3.47e-05	5.23e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—TGFB1—Alzheimer's disease	3.47e-05	5.23e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CASP3—Alzheimer's disease	3.44e-05	5.18e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—TGFB1—Alzheimer's disease	3.43e-05	5.17e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ACHE—Alzheimer's disease	3.42e-05	5.16e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—IL6—Alzheimer's disease	3.42e-05	5.15e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—MAPK8—Alzheimer's disease	3.4e-05	5.13e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	3.38e-05	5.1e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—IL6—Alzheimer's disease	3.37e-05	5.08e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—TP53—Alzheimer's disease	3.36e-05	5.06e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—TP53—Alzheimer's disease	3.26e-05	4.91e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	3.21e-05	4.84e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ENO1—Alzheimer's disease	3.21e-05	4.84e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—TP53—Alzheimer's disease	3.2e-05	4.83e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—MAPK8—Alzheimer's disease	3.16e-05	4.77e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—AKT1—Alzheimer's disease	3.15e-05	4.75e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	3.15e-05	4.74e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—VEGFA—Alzheimer's disease	3.14e-05	4.73e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—AKT1—Alzheimer's disease	3.11e-05	4.69e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—IL6—Alzheimer's disease	3.1e-05	4.67e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—AKT1—Alzheimer's disease	3.08e-05	4.64e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—IL6—Alzheimer's disease	3.07e-05	4.64e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—TP53—Alzheimer's disease	3.05e-05	4.6e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—BCHE—Alzheimer's disease	2.98e-05	4.5e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—IL6—Alzheimer's disease	2.98e-05	4.5e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—TP53—Alzheimer's disease	2.97e-05	4.47e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—IL6—Alzheimer's disease	2.93e-05	4.42e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—VEGFA—Alzheimer's disease	2.92e-05	4.4e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TGFB1—Alzheimer's disease	2.88e-05	4.34e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—AKT1—Alzheimer's disease	2.86e-05	4.31e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—TP53—Alzheimer's disease	2.86e-05	4.31e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—AKT1—Alzheimer's disease	2.84e-05	4.28e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—TP53—Alzheimer's disease	2.82e-05	4.25e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	2.81e-05	4.24e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—IL6—Alzheimer's disease	2.79e-05	4.21e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.76e-05	4.16e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—AKT1—Alzheimer's disease	2.75e-05	4.15e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	2.73e-05	4.11e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—IL6—Alzheimer's disease	2.72e-05	4.09e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—AKT1—Alzheimer's disease	2.71e-05	4.08e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TGFB1—Alzheimer's disease	2.68e-05	4.04e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—IL6—Alzheimer's disease	2.61e-05	3.94e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—IL6—Alzheimer's disease	2.58e-05	3.89e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—AKT1—Alzheimer's disease	2.58e-05	3.88e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—AKT1—Alzheimer's disease	2.51e-05	3.78e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—AKT1—Alzheimer's disease	2.41e-05	3.64e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—AKT1—Alzheimer's disease	2.38e-05	3.59e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TP53—Alzheimer's disease	2.37e-05	3.58e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	2.35e-05	3.55e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	2.34e-05	3.53e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TP53—Alzheimer's disease	2.2e-05	3.32e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—IL6—Alzheimer's disease	2.17e-05	3.27e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—LPL—Alzheimer's disease	2.14e-05	3.23e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—IL6—Alzheimer's disease	2.02e-05	3.04e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—AKT1—Alzheimer's disease	2e-05	3.02e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.93e-05	2.91e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—AKT1—Alzheimer's disease	1.86e-05	2.81e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.8e-05	2.72e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.79e-05	2.71e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.78e-05	2.68e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.56e-05	2.36e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—INS—Alzheimer's disease	1.53e-05	2.31e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.34e-05	2.03e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.23e-05	1.85e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—AKT1—Alzheimer's disease	6.18e-06	9.32e-06	CbGpPWpGaD
